Please login to the form below

Not currently logged in
Email:
Password:

Lilly promotes Joshua Smiley to new finance role

He will replace Thomas Grein, who is retiring in next month

Lilly has promoted Joshua Smiley to senior vice president, finance and treasurer to replace Thomas Grein, who will retire in September.

Smiley, who currently serves as senior vice president, finance and controller and chief financial officer for Lilly Research Laboratories (LRL), will report to Derica Rice, executive vice president, Global Services, and chief financial officer.

Rice said: "Josh's knowledge and skill helped to place Lilly in a position of strength. Josh is a strong analytical and strategic thinker who excels at distilling complex business matters into clear thoughts and actions."

Smiley has worked at Lilly for 21 years, serving in a variety of financial, marketing and Six Sigma roles.

He has been in his current role since 2011 and before that was vice president, finance, and chief financial officer for LRL and Lilly Oncology. 

When he takes up his new role on October 1 Smiley will in turn be replaced by vice president, finance, and chief financial officer for Lilly Manufacturing, Global Quality and Lilly Diabetes Anat Ashkenazi.

"Anat has a very effective ability to apply strategy into practical solutions,” Rice said. “Her exposure to many parts of our organisation - including R&D, manufacturing and commercial - combined with her learning agility, energy and commitment, position Anat well for her new role."

23rd August 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics